Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests
- Thursday, April 16, 2026, 7:01
- Health, Sports
- Add a comment
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.